Podcast thumbnail for Money in the Bank with Franck

Money in the Bank with Franck

Claim This Podcast

by Talking all things money - and having some fun along the way!

232 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
34

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality67
Social0
YouTube0
Engagement0

Podcast Overview

With over 20 years on Wall Street, Franck talks about the stock market and gives practical advice about all things financial. From financial planning to asset management, Franck talks about how the financial world works in practical and everyday language. His experience working for and with some of the largest financial services companies in the world gives him a unique insight to how things get done in the industry, and as a business owner he is also in touch with the dilemma’s that go along with that side of the financial universe. <br/><br/><a href="https://franckcushner.substack.com?utm_medium=podcast">franckcushner.substack.com</a>

Language

🇺🇲

Publishing Since

9/22/2016

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

34

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality67
Social0
YouTube0
Engagement0
7
Excellent Areas
2
Good Performance
10
Growth Opportunities
excellent
Episode Length
42 minutes
Performing excellently!
good
Publishing Consistency
Every 14 days

Recommendations available

Unlock the full report to see detailed tips

poor
Episode Thumbnails

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for Money in the Bank with Franck

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for The Sugar Breakthrough That Finally Cleared Its Biggest Hurdle

July 24, 2026

The Sugar Breakthrough That Finally Cleared Its Biggest Hurdle

<p>When Ed Rogers last joined Money in the Bank with Franck, Bonumose was still fighting a battle that had little to do with taste, demand or science.</p><p>The problem was the label.</p><p>Tagatose, the rare sugar Bonumose produces, had been classified by the FDA as an added sugar because it is technically a monosaccharide. That classification remained in place even though tagatose behaves very differently from conventional sugar and has properties more commonly associated with fiber.</p><p>Bonumose challenged the decision in federal court and won. But even after the ruling, the company still had to wait for the FDA to act.</p><p>Now, that barrier has finally been removed.</p><p>“The FDA still had not followed what the court told them to do,” Rogers said, reflecting on the period after the ruling. “Shortly after we spoke in October 2025, we did get a decision from the FDA that tagatose was going to be exempted and now is exempted from being classified as added sugars on nutrition facts panels.”</p><p>That decision changed the company’s problem almost overnight.</p><p>Before, Bonumose had a demand problem. Food companies could see the potential of tagatose, but the added-sugar designation created confusion for consumers and made widespread adoption difficult.</p><p>Now, according to Rogers, the company has the opposite problem.</p><p>“We would say, based upon what we’re hearing from our commercial partners, that the demand is around 20 times what our plant capacity is,” he said.</p><p>In other words, the science is no longer the primary obstacle. Neither is labeling.</p><p>The bottleneck is production.</p><p>From regulatory fight to commercial scale</p><p>Bonumose currently produces tagatose at its facility in Virginia using starch from American-grown crops. The company’s process can use corn, wheat, potatoes and other starch sources, which are then converted into tagatose using proprietary enzymes.</p><p>Rogers emphasized that there is nothing inherent in the process that prevents large-scale production.</p><p>The challenge is bringing additional manufacturing partners online.</p><p>Bonumose is now in active discussions with starch producers and other companies that already understand the unit operations required to convert starch into sweeteners. At very large scale, Rogers believes some infrastructure currently used to produce high-fructose corn syrup could eventually be adapted for tagatose production.</p><p>That makes the opportunity larger than a single food ingredient.</p><p>It is also a domestic manufacturing story.</p><p>Bonumose’s tagatose is made from American-grown crops, and Rogers argues that large-scale rare-sugar production could support farmers, expand demand for non-GMO starch and reduce dependence on foreign supply chains.</p><p>He even compared the strategic importance of rare sugars to rare earth minerals.</p><p>“I can make a straight-faced argument that tagatose production, rare sugar production, is as important as rare earth mineral production,” Rogers said. “It is important to American health.”</p><p>Why tagatose is different</p><p>Tagatose is not an artificial sweetener and Bonumose did not invent it.</p><p>As Rogers put it, “God invented tagatose.”</p><p>The rare sugar occurs naturally in small quantities and was first commercialized decades ago. Bonumose’s innovation was developing a more scalable way to manufacture it.</p><p>Its appeal comes from a combination of taste, function and potential health benefits.</p><p>Tagatose has a taste and texture similar to conventional sugar, but Rogers says it has a much lower impact on blood sugar. It also behaves like a prebiotic, passing largely into the large intestine, where it can be fermented by beneficial gut bacteria.</p><p>According to Rogers, research has associated tagatose with the production of short-chain fatty acids such as butyrate, while also showing potential benefits related to blood sugar response, insulin response and oral health.</p><p>It is also recognized as non-cariogenic, meaning it does not contribute to tooth decay in the way conventional sugar does.</p><p>For food manufacturers, however, health benefits are only part of the equation.</p><p>Ingredients still have to taste good.</p><p>That is where tagatose may have an advantage over many existing sugar alternatives. Rogers argued that it compares favorably with sugar alcohols such as erythritol, xylitol and maltitol, particularly in taste, functionality and overall consumer experience.</p><p>The company does not expect tagatose to replace all conventional sugar, nor does it believe every product should rely on tagatose alone.</p><p>Instead, Rogers sees the future in blends.</p><p>Tagatose can be combined with conventional sugar to reduce glycemic impact, or paired with highly concentrated sweet proteins to create products with dramatically lower sugar content.</p><p>In categories such as soft drinks, ice cream and packaged foods, those blends could potentially deliver a more sugar-like experience without requiring manufacturers to compromise as heavily on taste or texture.</p><p>The next 24 months</p><p>For years, Bonumose’s biggest goal was clear: resolve the FDA labeling issue.</p><p>Now the company’s priorities have shifted.</p><p>Over the next 12 to 24 months, Rogers wants to bring significantly more production capacity online—enough that major food companies no longer have to worry about supply running out.</p><p>That means expanding manufacturing partnerships while continuing to improve the enzymes at the center of Bonumose’s process.</p><p>The faster, stronger and less expensive those enzymes become, the more affordable tagatose can become for the mass market.</p><p>Rogers is not focused on naming a specific chocolate bar, beverage or snack that will adopt tagatose first.</p><p>He believes those applications will follow once the supply is ready.</p><p>“I’m not gonna say, ‘Hey, I want to see tagatose in the XYZ chocolate bar or this cookie or this ice cream or this soft drink,’ because that will come,” he said. “It is the large-scale production.”</p><p>That may be the most important shift in the Bonumose story.</p><p>The company is no longer simply trying to prove that tagatose deserves a place in the food system.</p><p>It is trying to build enough of it to meet the demand already forming.</p><p>Watch the full conversation with Ed Rogers on Money in the Bank with Franck.</p> <br/><br/>This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit <a href="https://franckcushner.substack.com?utm_medium=podcast&#38;utm_campaign=CTA_1">franckcushner.substack.com</a>

Episode thumbnail for What Happens When Betting, Gaming, and Markets Become One App?

July 3, 2026

What Happens When Betting, Gaming, and Markets Become One App?

Franck Cushner interviews Joey Levy, founder and CEO of Betr, about merging betting, gaming, and financial markets into a single consumer app.

Episode thumbnail for Charity vs. Investing Is the Wrong Question

February 5, 2026

Charity vs. Investing Is the Wrong Question

Franck Cushner interviews John Parker, a pediatric-focused investor, about how capital can simultaneously achieve philanthropic goals and financial returns by investing in companies that improve children's health outcomes.

232 total episodes available

Recent guests on Money in the Bank with Franck

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Joey Levy

Guest

John Parker

Guest

Joel Feld

Guest

Ed Rogers

Guest

Dmitry Shapiro

Guest

Ian Colville

Guest

Chris Willis

Guest

Chandra Duggirala

Guest

Dr Youwei Yang

Guest

Kayla Shawn

Guest

Deep-dive analytics for Money in the Bank with Franck

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Money in the Bank with Franck?

With over 20 years on Wall Street, Franck talks about the stock market and gives practical advice about all things financial. From financial planning to asset management, Franck talks about how the financial world works in practical and everyday language. His experience working for and with some of the largest financial services companies in the world gives him a unique insight to how things get done in the industry, and as a business owner he is also in touch with the dilemma’s that go along with that side of the financial universe. <br/><br/><a href="https://franckcushner.substack.com?utm_medium=podcast">franckcushner.substack.com</a>

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.